West Pharmaceutical HR chief sells 7,524 shares
WEST PHARMACEUTICAL SERVICES INC (WST) reported that Sr.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
WEST PHARMACEUTICAL SERVICES INC (WST) reported that Sr. VP & Chief HR Officer Annette F. Favorite exercised employee stock options and sold the resulting common shares in mid-September 2026 under a Rule 10b5-1 trading plan. She exercised options for 7,524 shares at an exercise price of $89.64 per share, then sold 7,524 common shares in three transactions at prices between $345 and $365 per share. The options exercised were part of an award granted on February 20, 2018 that vested annually beginning February 20, 2019.
Insider Trade Summary 10b5-1
Exercise and Sale: 7,524 shares ($2.00M approx. pre-tax spread)
Exercise and Sale
9 txns
Insider
Favorite Annette F
Role
Sr. VP & Chief HR Officer
Sold
7,524 shs ($2.67M)
Approx. gross sale proceeds
$2.67M
Approx. exercise cost
$674K
Approx. pre-tax spread
$2.00M
Share of Position Sold
25.6%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1 | 2,524 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,524 | $89.64 | $226K |
| Sale | Common Stock | 2,524 | $365.00 | $921K |
| Exercise | Stock Option (Right to Buy) F1 | 2,500 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,500 | $89.64 | $224K |
| Sale | Common Stock | 2,500 | $355.00 | $888K |
| Exercise | Stock Option (Right to Buy) F1 | 2,500 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,500 | $89.64 | $224K |
| Sale | Common Stock | 2,500 | $345.00 | $863K |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 contracts (Direct);
Common Stock — 21,817.8098 shares (Direct)
Holdings Before and After:
Stock Option (Right to Buy), 7,524 to 0 contracts (Direct);
Common Stock, 21,817.8098 to 21,817.8098 shares (Direct)
Footnotes (1)
- F1. This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019.
Key Figures
Shares sold: 7,524 shares
Shares exercised: 7,524 shares
Option exercise price: $89.64 per share
+5 more
8 metrics
Shares sold
7,524 shares
Total WST common shares sold across three transactions in September 2026
Shares exercised
7,524 shares
Total option shares of WST common stock exercised via code M transactions
Option exercise price
$89.64 per share
Exercise price for the stock options granted on February 20, 2018
Sale price on September 11, 2026
$345.00 per share
Sale of 2,500 WST common shares
Sale price on September 14, 2026
$355.00 per share
Sale of 2,500 WST common shares
Sale price on September 15, 2026
$365.00 per share
Sale of 2,524 WST common shares
Option expiration date
February 20, 2028
Expiration for the stock option award exercised in these transactions
Net shares sold
7,524 shares
Net-sell direction reported in transaction summary
Key Terms
Stock Option (Right to Buy), derivative security, Rule 10b5-1 trading plan
3 terms
Stock Option (Right to Buy) financial
"The reporting person held a Stock Option (Right to Buy) with an exercise price"
derivative security financial
"Code M transactions reflect the exercise or conversion of a derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Rule 10b5-1 trading plan regulatory
"Transactions were reported as made under a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did WST report for Annette F. Favorite in this Form 4?
Annette F. Favorite exercised stock options for 7,524 shares of WEST PHARMACEUTICAL SERVICES INC and sold 7,524 common shares in related transactions on September 11, 14, and 15, 2026, according to the Form 4.
What was the stock option exercise price in the WST Form 4 transactions?
The stock options exercised by Annette F. Favorite had an exercise price of $89.64 per share, based on an award originally granted on February 20, 2018 and later exercised in three tranches.
Were the WST insider transactions made under a Rule 10b5-1 trading plan?
Yes. The filing indicates that the reported transactions by Annette F. Favorite were made under a Rule 10b5-1 trading plan, meaning they were executed pursuant to a pre-arranged trading arrangement.
What is the vesting history of the WST options exercised in this Form 4?
The options exercised were from an award granted on February 20, 2018 that vested in four equal annual installments beginning on February 20, 2019, according to the footnote in the Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.
